1. Home
  2. HIFS vs QTTB Comparison

HIFS vs QTTB Comparison

Compare HIFS & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIFS
  • QTTB
  • Stock Information
  • Founded
  • HIFS 1834
  • QTTB 2015
  • Country
  • HIFS United States
  • QTTB United States
  • Employees
  • HIFS N/A
  • QTTB N/A
  • Industry
  • HIFS Major Banks
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • HIFS Finance
  • QTTB Health Care
  • Exchange
  • HIFS Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • HIFS 506.7M
  • QTTB 434.0M
  • IPO Year
  • HIFS N/A
  • QTTB N/A
  • Fundamental
  • Price
  • HIFS $273.93
  • QTTB $32.95
  • Analyst Decision
  • HIFS
  • QTTB Strong Buy
  • Analyst Count
  • HIFS 0
  • QTTB 6
  • Target Price
  • HIFS N/A
  • QTTB $72.33
  • AVG Volume (30 Days)
  • HIFS 14.1K
  • QTTB 96.9K
  • Earning Date
  • HIFS 10-11-2024
  • QTTB 11-07-2024
  • Dividend Yield
  • HIFS 0.92%
  • QTTB N/A
  • EPS Growth
  • HIFS N/A
  • QTTB N/A
  • EPS
  • HIFS 10.55
  • QTTB N/A
  • Revenue
  • HIFS $58,408,000.00
  • QTTB N/A
  • Revenue This Year
  • HIFS N/A
  • QTTB N/A
  • Revenue Next Year
  • HIFS N/A
  • QTTB N/A
  • P/E Ratio
  • HIFS $25.97
  • QTTB N/A
  • Revenue Growth
  • HIFS N/A
  • QTTB N/A
  • 52 Week Low
  • HIFS $150.11
  • QTTB $9.18
  • 52 Week High
  • HIFS $300.00
  • QTTB $53.79
  • Technical
  • Relative Strength Index (RSI)
  • HIFS 53.18
  • QTTB 23.68
  • Support Level
  • HIFS $250.04
  • QTTB $46.02
  • Resistance Level
  • HIFS $300.00
  • QTTB $51.26
  • Average True Range (ATR)
  • HIFS 8.94
  • QTTB 3.85
  • MACD
  • HIFS 0.39
  • QTTB -1.63
  • Stochastic Oscillator
  • HIFS 47.82
  • QTTB 12.77

About HIFS Hingham Institution for Savings

Hingham Institution for Savings is a savings bank based in Hingham, Massachusetts, and is involved in the business of residential and commercial real estate mortgage lending and also financial and banking services. The bank's financial services include personal checking accounts, personal mortgages, home equity lines of credit, money market accounts, savings accounts, certificates of deposit, and business checking accounts. Its lending portfolio mainly encompasses commercial real estate, residential owner-occupied real estate, and loans for the construction of residential real estate.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: